Castle Biosciences, Inc. Stock
Equities
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.24 USD | +0.08% | 0.00% | +12.33% |
Financials (USD)
Sales 2024 * | 261M | Sales 2025 * | 261M | Capitalization | 669M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -56M | EV / Sales 2024 * | 1.61 x |
Net cash position 2024 * | 249M | Net cash position 2025 * | 201M | EV / Sales 2025 * | 1.79 x |
P/E ratio 2024 * |
-14.9
x | P/E ratio 2025 * |
-12.7
x | Employees | 638 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.97% |
Latest transcript on Castle Biosciences, Inc.
1 day | +0.08% | ||
Current month | +14.94% | ||
1 month | +26.25% | ||
3 months | -4.19% | ||
6 months | +23.42% | ||
Current year | +12.33% |
Managers | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Franklin Stokes
DFI | Director of Finance/CFO | 54 | 17-11-30 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Daniel Bradbury
CHM | Chairman | 62 | 12-08-31 |
G. Cole
BRD | Director/Board Member | 68 | 18-12-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.99% | 11 M€ | -6.03% | - | |
0.60% | 12 M€ | -.--% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 234 M€ | +5.72% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 24.24 | +0.08% | 246,374 |
24-05-16 | 24.22 | -0.57% | 285,481 |
24-05-15 | 24.36 | +1.88% | 241,095 |
24-05-14 | 23.91 | -1.40% | 221,513 |
24-05-13 | 24.25 | +0.04% | 218,948 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.33% | 669M | |
-4.67% | 12.32B | |
-5.19% | 8.07B | |
+9.45% | 5.92B | |
+28.50% | 5.52B | |
-8.09% | 4.21B | |
-55.31% | 2.99B | |
+13.49% | 2.73B | |
-1.34% | 2.43B | |
+32.24% | 2.29B |
- Stock Market
- Equities
- CSTL Stock